Alufluoride Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 14, 2025, 10:59 pm

Competitors of Alufluoride Ltd

All Competitor Stocks of Alufluoride Ltd

Quarterly Result

Last Updated: August 20, 2025, 12:00 am

Below is a detailed analysis of the quarterly data for Alufluoride Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 43.76 Cr.. The value appears to be declining and may need further review. It has decreased from 54.01 Cr. (Mar 2025) to 43.76 Cr., marking a decrease of 10.25 Cr..
• For Expenses, as of Jun 2025, the value is 36.51 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 46.44 Cr. (Mar 2025) to 36.51 Cr., marking a decrease of 9.93 Cr..
• For Operating Profit, as of Jun 2025, the value is 7.25 Cr.. The value appears to be declining and may need further review. It has decreased from 7.57 Cr. (Mar 2025) to 7.25 Cr., marking a decrease of 0.32 Cr..
• For OPM %, as of Jun 2025, the value is 16.57%. The value appears strong and on an upward trend. It has increased from 14.02% (Mar 2025) to 16.57%, marking an increase of 2.55%.
• For Other Income, as of Jun 2025, the value is 0.34 Cr.. The value appears strong and on an upward trend. It has increased from -2.02 Cr. (Mar 2025) to 0.34 Cr., marking an increase of 2.36 Cr..
• For Interest, as of Jun 2025, the value is 0.77 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.64 Cr. (Mar 2025) to 0.77 Cr., marking an increase of 0.13 Cr..
• For Depreciation, as of Jun 2025, the value is 2.29 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.25 Cr. (Mar 2025) to 2.29 Cr., marking an increase of 0.04 Cr..
• For Profit before tax, as of Jun 2025, the value is 4.53 Cr.. The value appears strong and on an upward trend. It has increased from 2.66 Cr. (Mar 2025) to 4.53 Cr., marking an increase of 1.87 Cr..
• For Tax %, as of Jun 2025, the value is 29.80%. The value appears to be improving (decreasing) as expected. It has decreased from 39.47% (Mar 2025) to 29.80%, marking a decrease of 9.67%.
• For Net Profit, as of Jun 2025, the value is 3.18 Cr.. The value appears strong and on an upward trend. It has increased from 1.60 Cr. (Mar 2025) to 3.18 Cr., marking an increase of 1.58 Cr..
• For EPS in Rs, as of Jun 2025, the value is 4.07. The value appears strong and on an upward trend. It has increased from 2.05 (Mar 2025) to 4.07, marking an increase of 2.02.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 3:59 am

Growth

Last Updated: September 5, 2025, 2:11 pm

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Alufluoride Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 23.13. This value is within the healthy range. It has increased from 22.59 (Mar 24) to 23.13, marking an increase of 0.54.
• For Diluted EPS (Rs.), as of Mar 25, the value is 23.13. This value is within the healthy range. It has increased from 22.59 (Mar 24) to 23.13, marking an increase of 0.54.
• For Cash EPS (Rs.), as of Mar 25, the value is 34.60. This value is within the healthy range. It has increased from 33.43 (Mar 24) to 34.60, marking an increase of 1.17.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 130.15. It has increased from 108.96 (Mar 24) to 130.15, marking an increase of 21.19.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 130.15. It has increased from 108.96 (Mar 24) to 130.15, marking an increase of 21.19.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 241.06. It has increased from 207.03 (Mar 24) to 241.06, marking an increase of 34.03.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 45.51. This value is within the healthy range. It has decreased from 45.64 (Mar 24) to 45.51, marking a decrease of 0.13.
• For PBIT / Share (Rs.), as of Mar 25, the value is 34.04. This value is within the healthy range. It has decreased from 34.60 (Mar 24) to 34.04, marking a decrease of 0.56.
• For PBT / Share (Rs.), as of Mar 25, the value is 30.89. This value is within the healthy range. It has increased from 30.57 (Mar 24) to 30.89, marking an increase of 0.32.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 23.13. This value is within the healthy range. It has increased from 22.40 (Mar 24) to 23.13, marking an increase of 0.73.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 23.13. This value is within the healthy range. It has increased from 22.59 (Mar 24) to 23.13, marking an increase of 0.54.
• For PBDIT Margin (%), as of Mar 25, the value is 18.88. This value is within the healthy range. It has decreased from 22.04 (Mar 24) to 18.88, marking a decrease of 3.16.
• For PBIT Margin (%), as of Mar 25, the value is 14.12. This value is within the healthy range. It has decreased from 16.71 (Mar 24) to 14.12, marking a decrease of 2.59.
• For PBT Margin (%), as of Mar 25, the value is 12.81. This value is within the healthy range. It has decreased from 14.76 (Mar 24) to 12.81, marking a decrease of 1.95.
• For Net Profit Margin (%), as of Mar 25, the value is 9.59. This value is within the healthy range. It has decreased from 10.81 (Mar 24) to 9.59, marking a decrease of 1.22.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 9.59. This value is within the healthy range. It has decreased from 10.90 (Mar 24) to 9.59, marking a decrease of 1.31.
• For Return on Networth / Equity (%), as of Mar 25, the value is 17.77. This value is within the healthy range. It has decreased from 20.89 (Mar 24) to 17.77, marking a decrease of 3.12.
• For Return on Capital Employeed (%), as of Mar 25, the value is 19.98. This value is within the healthy range. It has decreased from 25.47 (Mar 24) to 19.98, marking a decrease of 5.49.
• For Return On Assets (%), as of Mar 25, the value is 12.20. This value is within the healthy range. It has decreased from 13.76 (Mar 24) to 12.20, marking a decrease of 1.56.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.19. This value is below the healthy minimum of 0.2. It has increased from 0.09 (Mar 24) to 0.19, marking an increase of 0.10.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.22. This value is within the healthy range. It has increased from 0.19 (Mar 24) to 0.22, marking an increase of 0.03.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.36. It has increased from 1.34 (Mar 24) to 1.36, marking an increase of 0.02.
• For Current Ratio (X), as of Mar 25, the value is 5.05. This value exceeds the healthy maximum of 3. It has increased from 2.66 (Mar 24) to 5.05, marking an increase of 2.39.
• For Quick Ratio (X), as of Mar 25, the value is 3.78. This value exceeds the healthy maximum of 2. It has increased from 2.18 (Mar 24) to 3.78, marking an increase of 1.60.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 8.60. This value exceeds the healthy maximum of 8. It has increased from 7.53 (Mar 24) to 8.60, marking an increase of 1.07.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 8.85 (Mar 24) to 0.00, marking a decrease of 8.85.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 5.94 (Mar 24) to 0.00, marking a decrease of 5.94.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 91.15 (Mar 24) to 0.00, marking a decrease of 91.15.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 94.06 (Mar 24) to 0.00, marking a decrease of 94.06.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 14.44. This value is within the healthy range. It has increased from 11.33 (Mar 24) to 14.44, marking an increase of 3.11.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 8.34. This value is within the healthy range. It has increased from 6.56 (Mar 24) to 8.34, marking an increase of 1.78.
• For Enterprise Value (Cr.), as of Mar 25, the value is 379.89. It has increased from 373.36 (Mar 24) to 379.89, marking an increase of 6.53.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.02. This value is within the healthy range. It has decreased from 2.31 (Mar 24) to 2.02, marking a decrease of 0.29.
• For EV / EBITDA (X), as of Mar 25, the value is 10.67. This value is within the healthy range. It has increased from 10.46 (Mar 24) to 10.67, marking an increase of 0.21.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.92. This value is within the healthy range. It has decreased from 2.25 (Mar 24) to 1.92, marking a decrease of 0.33.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 91.14 (Mar 24) to 0.00, marking a decrease of 91.14.
• For Price / BV (X), as of Mar 25, the value is 3.56. This value exceeds the healthy maximum of 3. It has decreased from 4.32 (Mar 24) to 3.56, marking a decrease of 0.76.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.92. This value is within the healthy range. It has decreased from 2.25 (Mar 24) to 1.92, marking a decrease of 0.33.
• For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness